With 29% ownership in Elevation Oncology, Inc. (NASDAQ:ELEV), hedge funds investors have a lot riding on the business

Key Insights Significantly high institutional ownership implies Elevation Oncology's stock price is sensitive to their...

Related Keywords

,Elevation Oncology Inc ,Tang Capital Management ,Elevation Oncology ,Institutional Ownership ,Nc ,Institutional Investors ,Nsider Ownership ,Hedge Funds ,Hedge Funds Investors ,